PARP inhibitor–based combinations in first-line metastatic castration-resistant prostate cancer: A meta-analysis

Urologic Oncology: Seminars and Original Investigations · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles